A new grant award will allow an investigator at The Children’s Hospital of Philadelphia to study the effectiveness of certain drugs called retinoid agonists in slowing or preventing muscle degeneration in individuals with muscular dystrophy. Findings from the study could lead to new, ground-breaking treatment for those individuals.